[Perinatal outcomes and serological results in neonates of pregnant women seropositive to SARS-CoV-2: A cross-sectional descriptive study].

Autor:	Dávila-Aliaga C; Instituto Nacional Materno Perinatal, Lima, Perú; Universidad Nacional Federico Villarreal, Lima, Perú. ORCID: 0000-0001-9411-5703., Espínola-Sánchez M; Instituto Nacional Materno Perinatal, Lima, Perú; Universidad Privada del Norte, Lima, Perú. Email: marcosespinola.es@gmail.com. Address: Santa Rosa, 941, Cercado de Lima, Lima, Perú, 15003. ORCID: 0000-0002-1005-5158., Mendoza-Ibáñez E; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0001-6285-4464., Guevara-Ríos E; Instituto Nacional Materno Perinatal, Lima, Perú; Universidad Nacional Mayor de San Marcos, Lima, Perú. ORCID: 0000-0002-6962-2639., Torres-Marcos E; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0002-2718-6621., Hinojosa-Pérez R; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0002-6640-5102., Espinoza-Vivas Y; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0003-3466-7236., Álvarez-Carrasco R; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0002-0987-6717., Velásquez-Vásquez C; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0001-9209-2480., Meza-Santibáñez L; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0002-1817-8187., Gonzales-Carrillo O; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0001-9032-1542., Arango-Ochante P; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0002-3267-1904., Racchumí-Vela A; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0001-7695-1978., Saldaña-Díaz C; Instituto Nacional Materno Perinatal, Lima, Perú. ORCID: 0000-0003-3117-5332.
Jazyk:	Spanish; Castilian
Zdroj:	Medwave [Medwave] 2020 Dec 21; Vol. 20 (11), pp. e8084. Date of Electronic Publication: 2020 Dec 21.
DOI:	10.5867/medwave.2020.11.8084
Abstrakt:	Introduction: SARS-CoV-2 has spread rapidly throughout the world. However, its ability to cause severe disease is not homogeneous according to sex and the different age groups. Objective: To determine perinatal characteristics, morbidity, mortality, and serological results in neonates from seropositive pregnant women to SARS-CoV-2. Methods: We did a retrospective, descriptive, cross-sectional study. We included all newborns from positive pregnant women to SARS-CoV-2, between April 15 and May 10, 2020, who delivered in the National Perinatal Maternal Institute of Peru. The study extracted maternal and neonatal variables collected from the medical charts. The data were analyzed using descriptive statistics and Fischer's exact test. Results: One hundred fourteen neonates were identified, 36.8% IgM/IgG positive for SARS-CoV-2, 7% IgG, and 56.2% had negative serology. The obstetric complications were premature rupture of membranes (14.9%) and preterm birth (8,8%). 8.8% of newborns had an Apgar score of less than or equal to six minutes, and of those, only one persisted after five minutes; three newborns died. There was an association between the type of maternal immunoglobulin and the serology of the newborn (p < 0.05). No association was observed between perinatal results and maternal immunoglobulin type (p > 0.05) or serological results in the newborn for SARS-CoV-2 (p > 0.05). Conclusion: 43.9% of seropositive mothers' neonates to SARS-CoV-2 had a positive serological result, more frequently type IgM/IgG. 10.5% of the neonates had some morbidity, more frequent prematurity, low birth weight, and 2.6% died. Perinatal results were not associated with the type of immunoglobulin of mothers seropositive to SARS-CoV-2; similarly, perinatal results were not associated with serological results in the newborn.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu